Sigmapharm Laboratories, LLC FDA Inspection Record
Sigmapharm Laboratories, LLC is an FDA-registered facility (FEI 3005444934) located in Bensalem, PA, US. Registered operations: ANALYSIS; API MANUFACTURE; MANUFACTURE. RegDataLab tracks 12 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Dec 17, 2025: Voluntary Action Indicated (VAI)
- Inspections on record
- 12 (7 VAI, 5 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 4, latest Sep 21, 2021
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Dec 17, 2025 | Voluntary Action Indicated (VAI) | Extent of discrepancy, failure investigations (21 CFR 211.192) |
| Feb 13, 2023 | No Action Indicated (NAI) | No citations listed |
| Dec 7, 2021 | No Action Indicated (NAI) | No citations listed |
| Jun 13, 2018 | No Action Indicated (NAI) | No citations listed |
| Jun 19, 2017 | Voluntary Action Indicated (VAI) | Review of representative number of batches (21 CFR 211.180(e)(1)) |
| Jun 23, 2015 | No Action Indicated (NAI) | No citations listed |
| Nov 19, 2014 | Voluntary Action Indicated (VAI) | Approve or reject procedures or specs (21 CFR 211.22(c)) Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a)) Maintenance of Complaint File (21 CFR 211.198(b)) Control procedures to monitor and validate performance (21 CFR 211.110(a)) and 2 more |
| Mar 20, 2014 | Voluntary Action Indicated (VAI) | No citations listed |
| Aug 13, 2013 | Voluntary Action Indicated (VAI) | Failure to review ADE information (21 CFR 314.80(b)) Incomplete periodic safety report (21 CFR 314.80(c)(2)(ii)(A)) |
| Dec 22, 2011 | Voluntary Action Indicated (VAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Sep 21, 2021 | Class II | D-0898-2021 | Sodium Phenylbutyrate Powder, 250 Grams, Rx Only, packaged in 500 cc HDPE bottles and 53… Failed Impurities/Degradation Specifications; Out of Specification impurity results obtained during routine testing. |
| Aug 13, 2021 | Class II | D-0766-2021 | Sodium Phenylbutyrate POWDER, 250 grams bottle, Rx Only, Sigmapharm Laboratories, LLC… Failed Impurities Specifications: Out of Specification impurity results obtained during routine testing. |
| Apr 19, 2021 | Class III | D-0379-2021 | Asenapine Sublingual Tablets, 5 mg, Rx Only, 60 Tablets, Sigmapharm Laboratories, LLC… and 1 more product Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry… |
| Apr 22, 2014 | Class II | D-1344-2014 | Liothyronine Sodium Tablets, USP 5 mcg, Rx Only, a) 100-count bottle NDC 42794-018-02 and… Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a… |
FDA record score
10 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
10 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Dec 17, 2025 | 6 x 1 | 6 |
| Inspection classified VAI | Jun 19, 2017 | 6 x 0.25 | 1.5 |
| Class II recall D-0898-2021, this FEI as the recalling firm | Sep 21, 2021 | 4 x 0.25 | 1 |
| Class II recall D-0766-2021, this FEI as the recalling firm | Aug 13, 2021 | 4 x 0.25 | 1 |
| Inspection classified VAI | Nov 19, 2014 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1344-2014, this FEI as the recalling firm | Apr 22, 2014 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Mar 20, 2014 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Aug 13, 2013 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Dec 22, 2011 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | May 25, 2011 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 17, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Sigmapharm Laboratories, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Sigmapharm Laboratories, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- SigmaPharm Laboratories LLC
- Location
- Bensalem, PA (US)
- Registration Expires
- Dec 31, 2027
- Operations
- ANALYSIS; API MANUFACTURE; MANUFACTURE
- Source
- decrs